South Asians are a diverse population with unique genetic, cultural, and environmental factors that directly impact their overall health. Pre-disposed to several chronic illness such as cardiovascular disease, diabetes, obesity, and even some cancer, it is incredibly important to have adequate health data on this demographic to help diagnose and prevent these disease states. However, there is very limited data on South Asians and the reason behind this is multifold. First, barriers exist that specifically impact participation rates in ethnic minority groups such as South Asians. Next, a majority of clinical research studies utilize aggregated race and ethnicity categories, such as White, Black, Asian, American Indian, and Latino, which tend to cover up the individual health needs of its ethnic subgroups like South Asian.
A literature review involving 20 published works and texts was carried out to determine the barriers that prevent clinical trial engagement in South Asians. The primary reasons for lack of involvement of South Asians in clinical trials were language difference, trial burden, lack of information, mistrust, gender roles, and of course the systemic insufficiency in actively recruiting specifically South Asian populations.
In order to achieve health equity, it is essential to understand health disparities that exist within the system and work to find methods to alleviate them.
| Identifer | oai:union.ndltd.org:bu.edu/oai:open.bu.edu:2144/48384 |
| Date | 09 March 2024 |
| Creators | Singh, Jujhar |
| Contributors | Offner, Gwynneth, Garcia Diaz, J. Fernando |
| Source Sets | Boston University |
| Language | en_US |
| Detected Language | English |
| Type | Thesis/Dissertation |
Page generated in 0.0015 seconds